BioMarin Pharmaceutical, Inc. (BMRN)
56.58
-0.18
(-0.33%)
USD |
NASDAQ |
Jun 08, 16:00
56.58
0.00 (0.00%)
After-Hours: 19:07
BioMarin Pharmaceutical Total Assets (Quarterly) : 8.591B for March 31, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Ionis Pharmaceuticals, Inc. | 3.450B |
| Alnylam Pharmaceuticals, Inc. | 5.130B |
| Incyte Corp. | 7.339B |
| Mirum Pharmaceuticals, Inc. | 890.92M |
| Cytokinetics, Inc. | 1.273B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 2.379B |
| Shareholders Equity (Quarterly) | 6.212B |
| Debt to Equity Ratio | 0.2328 |
| Current Ratio | 5.806 |
| Net Debt Paydown Yield | -1.46% |